Skip to main content
. 2020 Sep 16;19:105–126. doi: 10.1016/j.omto.2020.09.003

Figure 7.

Figure 7

The Prognostic Value of Nuclear Factor TRIP-Brs in BRCA Patients

(A) Prognostic value of TRIP-Br-1 showed overall survival (OS; GENT2 datasets analysis), relapse-free survival (RFS; PrognoScan datasets), distant metastasis-free survival (DMFS), and PFS for TRIP-Br-1 in BRCA. (B–E) The prognostic values for each TRIP-Br were analyzed using KM plotter based on their median expression in BRCA patients. The Kaplan-Meier (KM) survival curve showed OS, RFS, DMFS, and disease-free survival (DFS) in low and higher TRIP-Br-expressing patient groups using KM plotter of GEO, European Genome-Phenome Archive (EGA), and TCGA datasets.